OCCUDO QUANTITATIVE STRATEGIES LP - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 68 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.

Quarter-by-quarter ownership
OCCUDO QUANTITATIVE STRATEGIES LP ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$76,807
+140.0%
26,762
+42.6%
0.01%
+400.0%
Q3 2022$32,000
-34.7%
18,764
-5.3%
0.00%
-50.0%
Q2 2022$49,000
-34.7%
19,807
-27.0%
0.00%
-33.3%
Q1 2022$75,000
-69.6%
27,123
-41.6%
0.01%
-72.7%
Q4 2021$247,000
-25.6%
46,426
+18.2%
0.02%
-45.0%
Q3 2021$332,000
-74.2%
39,282
-62.7%
0.04%
-79.6%
Q2 2021$1,285,000
+283.6%
105,396
+907.0%
0.20%
+86.7%
Q4 2020$335,00010,4660.10%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q3 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 634,191$1,820,1282.14%
NEA Management Company, LLC 4,448,757$12,767,9330.99%
CHI Advisors LLC 720,000$2,066,4000.82%
Bellevue Group AG 8,135,839$23,349,8580.38%
Parkman Healthcare Partners LLC 520,587$1,494,0850.27%
Artal Group S.A. 2,046,517$5,8740.25%
RA Capital Management 3,525,754$10,118,9140.20%
Ikarian Capital, LLC 555,572$1,594,4920.19%
TANG CAPITAL MANAGEMENT LLC 400,000$1,148,0000.16%
Newtyn Management, LLC 205,000$588,3500.14%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders